New Opportunities in Non-Preservative Glaucoma Therapy
Most of the medicines used for the treatment of glaucoma include a preservative in various concentrations. With long-term topical therapy, patients with glaucoma may develop dry eye syndrome (DES). The severity of symptoms depends on the number of drugs used and the presence of a preservative in the...
Main Authors: | A. A. Antonov, I. V. Kozlova, A. A. Vitkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2021-07-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/1542 |
Similar Items
-
Intraocular pressure-lowering effects of commonly used fixed combination drugs with timolol in the management of primary open angle glaucoma
by: Murat Atabey Ozer, et al.
Published: (2014-10-01) -
Comparative Evaluation of the Efficacy and Safety of Brimonidine Generics in Glaucoma Therapy
by: A. A. Antonov, et al.
Published: (2023-12-01) -
Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01) -
Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
by: Sang-Woo Park, et al.
Published: (2022-02-01) -
Impact of combination of local carbonic anhydrase inhibitors and beta-blockers on intraocular pressure, visual functions and eye hemodynamics in primary open-angle glaucoma
by: T. N. Malishevskaya, et al.
Published: (2021-06-01)